Clinical Trials Browser

OTHER × Breast Neoplasms × Ketorolac × Clear all

NCT06150898 2025-06-13

KePreSt

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

NCT02141139 2014-05-19

Perioperative Inflammation and Breast Cancer Outcome

Phase 3 Unknown

Breast Neoplasms, Inflammation